Market Performance
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reached a new 52-week high of $974.00 during today's trading session.
The Healthcare stock has traded year-to-date and 1.3% over the past week. The previous 52-week high was $974.00.
52 week highNASDAQ:REGN
Regeneron Pharmaceuticals, Inc. (REGN) Hits New 52-Week High of $974.00
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reached a new 52-week high of $974.00 during today's trading session.
At publication ·
What changed
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) · 52 week high
- Price at event
- $973.42
- Price change
- 1.27%
- Average volume to event volume
- 1.1M to 904.2K
- 52-week high
- $974.00
- 52-week low
- $591.52
At a glance
Key takeaways
- Regeneron Pharmaceuticals reached a new 52-week high of $974.00 with a market capitalization of $77.2 billion.
Company Overview
Regeneron Pharmaceuticals, Inc. has a market capitalization of $77.2B. The stock's 52-week low was $591.52.
Reaching a 52-week high often signals strong momentum and investor confidence in Regeneron Pharmaceuticals, Inc. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
Regeneron Pharmaceuticals, Inc. currently trades at $973.42, positioning the stock at the 100th percentile of its 52-week range ($591.52 — $974.00). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View REGN Stock Page
Frequently Asked Questions
What is causing REGN's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our REGN news page.
What is REGN's 52-week range?
See full price history and interactive charts on our REGN chart page.
